Chief Technical Operations and Quality Officer, Alnylam Pharmaceuticals

Dr. Alfred “Al” Boyle joined Alnylam in 2015 with over 20 years of experience within the biotechnology, pharmaceutical and chemical industries. He leads a team accountable for all aspects of CMC development, clinical and commercial product manufacturing and supply, enterprise GxP Quality oversight and facilities and engineering operations globally.
Prior to joining Alnylam, Al served as Vice President of Global Technical Services at Alexion Pharmaceuticals where he was responsible for technology transfer and process oversight of cGMP manufacturing of clinical and commercial products. Prior to this role, Al served as Vice President, Technical Operations in Switzerland and Ireland also with Alexion. For this position, he led an organization in Switzerland accountable for business, technical and quality oversight of drug substance, drug product and finished product contract manufacturing organizations; and led the relocation of this organization to Ireland. Prior to Alexion, Al spent over eight years with Bristol-Myers Squibb, overseeing fermentation and biocatalysis development, technology transfer and commercial manufacturing support of biologics products. He also held positions in the Research and Development functions of Celgene Corporation, Akzo-Nobel and Hercules Inc.
Dr. Boyle obtained his Bachelor of Science and Master of Science degrees from the State University of New York College of Environmental Science and Forestry and a Ph.D. in Microbiology from Rutgers University.


23 September 2021